{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:39:22Z","timestamp":1787895562030,"version":"build-2784847793"},"reference-count":48,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T00:00:00Z","timestamp":1569974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.vaccine.2019.09.094","type":"journal-article","created":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T17:09:48Z","timestamp":1571072988000},"page":"7165-7170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Factors influencing participation in an Ebola vaccine trial among front-line workers in Guinea"],"prefix":"10.1016","volume":"37","author":[{"given":"Kyra H.","family":"Grantz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Claudot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micky","family":"Kambala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariama","family":"Kouyat\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aboubacar","family":"Soumah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yap","family":"Boum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aitana","family":"Juan-Giner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Jemmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek A.T.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5037-8218","authenticated-orcid":false,"given":"Rebecca F.","family":"Grais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.09.094_b0005","unstructured":"WHO Clinical Response Team. Ebola Situation Report - 6 January 2016; 2016."},{"key":"10.1016\/j.vaccine.2019.09.094_b0010","unstructured":"WHO Clinical Response Team. Ebola Situation Report - 30 March 2016; 2016."},{"key":"10.1016\/j.vaccine.2019.09.094_b0015","article-title":"The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola","volume":"351","author":"Ebola ca suffit ring vaccination trial consortium","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2019.09.094_b0020","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0140-6736(15)60035-6","article-title":"Ebola vaccine trials back on track","volume":"385","author":"Mohammadi","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.09.094_b0025","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","volume":"386","author":"Henao-Restrepo","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.09.094_b0030","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!)","author":"Henao-Restrepo","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.09.094_b0035","unstructured":"World Health Organization. Preliminary results on the efficacy of rVSV-ZEBOV-GP Ebola vaccine using the ring vaccination strategy in the control of an Ebola outbreak in the Democratic Republic of Congo; 2019."},{"key":"10.1016\/j.vaccine.2019.09.094_b0040","unstructured":"World Health Organization. Ebola Virus Disease, Democratic Republic of the Congo: External Situation Report 54; 2019."},{"key":"10.1016\/j.vaccine.2019.09.094_b0045","unstructured":"WHO | Health worker Ebola infections in Guinea, Liberia and Sierra Leone. WHO 2016."},{"key":"10.1016\/j.vaccine.2019.09.094_b0050","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/1099800403252603","article-title":"A current review of Ebola virus: pathogenesis, clinical presentation, and diagnostic assessment","volume":"4","author":"Casillas","year":"2003","journal-title":"Biol Res Nurs"},{"key":"10.1016\/j.vaccine.2019.09.094_b0055","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7748\/nr2002.10.10.1.30.c5877","article-title":"An overview of three different approaches to the interpretation of qualitative data. Part 1: theoretical issues","volume":"10","author":"Priest","year":"2002","journal-title":"Nurse Res"},{"key":"10.1016\/j.vaccine.2019.09.094_b0060","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/1049732305276687","article-title":"Three approaches to qualitative content analysis","volume":"15","author":"Hsieh","year":"2005","journal-title":"Qual Health Res"},{"key":"10.1016\/j.vaccine.2019.09.094_b0065","first-page":"5","article-title":"Content analysis: concepts, methods and applications","volume":"4","author":"Cavanagh","year":"1997","journal-title":"Nurse Res"},{"key":"10.1016\/j.vaccine.2019.09.094_b0070","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2648.2007.04569.x","article-title":"The qualitative content analysis process","volume":"62","author":"Elo","year":"2008","journal-title":"J Adv Nurs"},{"key":"10.1016\/j.vaccine.2019.09.094_b0075","series-title":"The SAGE handbook of qualitative research","author":"Denzin","year":"2005"},{"key":"10.1016\/j.vaccine.2019.09.094_b0080","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/1043659605278935","article-title":"Providing care and facing death: nursing during Ebola Outbreaks in Central Africa","volume":"16","author":"Hewlett","year":"2005","journal-title":"J Transcult Nurs"},{"key":"10.1016\/j.vaccine.2019.09.094_b0085","article-title":"Ebola virus disease stigmatization; the role of societal attributes","volume":"8","author":"Obilade","year":"2015","journal-title":"Int Arch Med"},{"key":"10.1016\/j.vaccine.2019.09.094_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165271","article-title":"Preparation and response to the 2014 Ebola Virus Disease Epidemic in Nigeria\u2014the experience of a tertiary hospital in Nigeria","volume":"11","author":"Ogoina","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.09.094_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072094","article-title":"A qualitative analysis of factors influencing HPV Vaccine Uptake in Soweto, South Africa among adolescents and their Caregivers","volume":"8","author":"Katz","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.09.094_b0100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00042560-200101010-00010","article-title":"Willingness to volunteer in future preventive HIV Vaccine Tr... : JAIDS Journal of Acquired Immune Deficiency Syndromes","volume":"26","author":"Strauss","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.vaccine.2019.09.094_b0105","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0277-9536(98)00317-7","article-title":"An evaluation of the informed consent procedure used during a trial of a Haemophilus influenzae type B conjugate vaccine undertaken in The Gambia, West Africa","volume":"48","author":"Leach","year":"1999","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.vaccine.2019.09.094_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080800","article-title":"Could the decision of trial participation precede the informed consent process? Evidence From Burkina Faso","volume":"8","author":"Par\u00e9 Toe","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2019.09.094_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2307\/3563534","article-title":"Motivations, understanding, and voluntariness in international randomized trials","volume":"27","author":"Kass","year":"2005","journal-title":"IRB"},{"key":"10.1016\/j.vaccine.2019.09.094_b0120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4314\/mmj.v20i2.10898","article-title":"Why do individuals agree to enrol in clinical trials? A qualitative study of health research participation in Blantyre, Malawi","volume":"20","author":"Mfutso-Bengo","year":"2008","journal-title":"Malawi Med J"},{"key":"10.1016\/j.vaccine.2019.09.094_b0125","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/tmi.12288","article-title":"Informed consent comprehension in African research settings","volume":"19","author":"Afolabi","year":"2014","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.vaccine.2019.09.094_b0130","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1191\/1740774506cn150oa","article-title":"Problems in comprehension of informed consent in rural and peri-urban Mali, West Africa","volume":"3","author":"Krosin","year":"2006","journal-title":"Clin Trials"},{"key":"10.1016\/j.vaccine.2019.09.094_b0135","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1017\/S0021932005000945","article-title":"Public engagement with science? Local understandings of a vaccine trial in the Gambia","volume":"38","author":"Fairhead","year":"2006","journal-title":"J Biosoc Sci"},{"key":"10.1016\/j.vaccine.2019.09.094_b0140","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.socscimed.2006.02.018","article-title":"Where techno-science meets poverty: Medical research and the economy of blood in The Gambia, West Africa","volume":"63","author":"Fairhead","year":"2006","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.vaccine.2019.09.094_b0145","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/jme.2004.009910","article-title":"Informed consent and participant perceptions of influenza vaccine trials in South Africa","volume":"31","author":"Moodley","year":"2005","journal-title":"J Med Ethics"},{"key":"10.1016\/j.vaccine.2019.09.094_b0150","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM199701303360511","article-title":"Practical experiences in obtaining informed consent for a vaccine trial in rural Africa","author":"Preziosi","year":"1997","journal-title":"Engl J"},{"key":"10.1016\/j.vaccine.2019.09.094_b0155","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.socscimed.2004.11.073","article-title":"Trust and informed consent: insights from community members on the Kenyan coast","volume":"61","author":"Molyneux","year":"2005","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.vaccine.2019.09.094_b0160","first-page":"5","article-title":"Behavioural and emotional responses to the 2014 Ebola outbreak in Nigeria: a narrative review","volume":"8","author":"Ogoina","year":"2016","journal-title":"Int Health"},{"key":"10.1016\/j.vaccine.2019.09.094_b0165","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/tmi.12528","article-title":"Ebola virus disease - gaps in knowledge and practice among healthcare workers in Lagos, August 2014","volume":"20","author":"Oladimeji","year":"2015","journal-title":"Trop Med Int Heal"},{"key":"10.1016\/j.vaccine.2019.09.094_b0170","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.socscimed.2008.02.003","article-title":"Taking social relationships seriously: Lessons learned from the informed consent practices of a vaccine trial on the Kenyan Coast","volume":"67","author":"Gikonyo","year":"2008","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.vaccine.2019.09.094_b0175","doi-asserted-by":"crossref","unstructured":"Wolfe RM, Sharp LK, Lipsky MS, SB G, H T, H T, et al. Content and design attributes of antivaccination web sites. JAMA 2002;287:3245. doi:10.1001\/jama.287.24.3245.","DOI":"10.1001\/jama.287.24.3245"},{"key":"10.1016\/j.vaccine.2019.09.094_b0180","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1016\/j.vaccine.2012.06.025","article-title":"A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in northwest Tanzania","volume":"30","author":"Remes","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.09.094_b0185","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1467-842X.1998.tb01411.x","article-title":"Vaccine preventable diseases and immunisations: a qualitative study of mothers? Perceptions of severity, susceptibility, benefits and barriers","volume":"22","author":"Bond","year":"1998","journal-title":"Aust N Z J Public Health"},{"key":"10.1016\/j.vaccine.2019.09.094_b0190","doi-asserted-by":"crossref","first-page":"8760","DOI":"10.1016\/j.vaccine.2011.07.116","article-title":"A qualitative analysis of South African women\u2019s knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health","volume":"29","author":"Francis","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.09.094_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005077","article-title":"Fears and Misperceptionsof the Ebola Response System during the 2014\u20132015 Outbreak in Sierra Leone","volume":"10","author":"Yamanis","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.09.094_b0200","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1186\/s12889-016-3799-x","article-title":"Power, fairness and trust: understanding and engaging with vaccine trial participants and communities in the setting up the EBOVAC-Salone vaccine trial in Sierra Leone","volume":"16","author":"Enria","year":"2016","journal-title":"BMC Public Health"},{"issue":"11","key":"10.1016\/j.vaccine.2019.09.094_b0205","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jclinepi.2005.09.002","article-title":"Systematic review of qualitative studies exploring parental beliefs and attitudes toward childhood vaccination identifies common barriers to vaccination","volume":"58","author":"Mills","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2019.09.094_b0210","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1002\/1097-0142(19941101)74:9+<2687::AID-CNCR2820741817>3.0.CO;2-B","article-title":"Clinical trial participation: viewpoints from racial\/ethnic groups","volume":"74","author":"Roberson","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.vaccine.2019.09.094_b0215","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJMp1508413","article-title":"Community trust and the Ebola Endgame","volume":"373","author":"Dhillon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.09.094_b0220","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4269\/ajtmh.13-0630","article-title":"Doctors and vampires in sub-Saharan Africa: ethical challenges in clinical trial research","volume":"91","author":"Grietens","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2019.09.094_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(14)62392-8","article-title":"Blood as medicine: social meanings of blood and the success of Ebola trials","volume":"385","author":"Bannister-Tyrrell","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.09.094_b0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040073","article-title":"What Led to the Nigerian Boycott of the Polio Vaccination Campaign?","volume":"4","author":"Jegede","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2019.09.094_b0235","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.vaccine.2019.03.004","article-title":"Ebola epidemic in war-torn Democratic Republic of Congo, 2018: Acceptability and patient satisfaction of the recombinant Vesicular Stomatitis Virus \u2013 Zaire Ebolavirus Vaccine","volume":"37","author":"Kasereka","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.09.094_b0240","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMsr1904253","article-title":"The Ongoing Ebola Epidemic in the Democratic Republic of Congo, 2018\u20132019","volume":"381","author":"Ilunga Kalenga","year":"2019","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19313362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19313362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:36:23Z","timestamp":1759401383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19313362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":48,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0264410X19313362"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.094","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors influencing participation in an Ebola vaccine trial among front-line workers in Guinea","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.094","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}